CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY (unaudited) - USD ($) $ in Thousands	Total	Preferred Stock	Additional Paid-In Capital	Retained Earnings	Treasury Stock	Accumulated Other Comprehensive Income (Loss)	Restricted Stock	Restricted Stock Additional Paid-In Capital	Restricted Stock Treasury Stock	Performance Based Restricted Stock Awards	Performance Based Restricted Stock Awards Additional Paid-In Capital	Performance Based Restricted Stock Awards Treasury Stock
Beginning balance at Dec. 31, 2022	$ 530,762	$ 57,785	$ 221,553	$ 306,911	$ (2,967)	$ (52,520)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	44,043			44,043
Other comprehensive income (loss)	(5,981)					(5,981)
Forfeiture of restricted stock award grants	0		90		(90)
Restricted stock award grants and Performance-based restricted stock award grants							$ 0	$ (2,743)	$ 2,743	$ 0	$ (111)	$ 111
Stock-based compensation expense	1,311		1,311
Purchase of treasury stock	(6,556)				(6,556)
Purchase of treasury stock for the purpose of tax withholding related to restricted stock award vesting							(89)		(89)	(14)		(14)
Preferred cash dividend declared	(3,226)			(3,226)
Cash dividends declared	(11,038)			(11,038)
Ending balance at Sep. 30, 2023	549,212	57,785	220,100	336,690	(6,862)	(58,501)
Beginning balance at Jun. 30, 2023	549,634	57,785	219,723	327,707	(4,996)	(50,585)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	13,727			13,727
Other comprehensive income (loss)	(7,916)					(7,916)
Forfeiture of restricted stock award grants	0		27		(27)
Stock-based compensation expense	350		350
Purchase of treasury stock	(1,839)				(1,839)
Purchase of treasury stock for the purpose of tax withholding related to restricted stock award vesting							0		0
Preferred cash dividend declared	(1,076)			(1,076)
Cash dividends declared	(3,668)			(3,668)
Ending balance at Sep. 30, 2023	549,212	57,785	220,100	336,690	(6,862)	(58,501)
Beginning balance at Dec. 31, 2023	571,247	57,785	220,495	345,935	(6,890)	(46,078)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	39,511			39,511
Other comprehensive income (loss)	8,782					8,782
Forfeiture of restricted stock award grants	0		177		(177)
Restricted stock award grants and Performance-based restricted stock award grants							0	$ (3,025)	3,025	0	$ (179)	179
Stock-based compensation expense	1,836		1,836
Purchase of treasury stock	(441)				(441)
Purchase of treasury stock for the purpose of tax withholding related to restricted stock award vesting							(158)		(158)	$ (54)		$ (54)
Preferred cash dividend declared	(3,226)			(3,226)
Cash dividends declared	(11,134)			(11,134)
Ending balance at Sep. 30, 2024	606,363	57,785	219,304	371,086	(4,516)	(37,296)
Beginning balance at Jun. 30, 2024	586,700	57,785	218,756	361,987	(4,438)	(47,390)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	13,954			13,954
Other comprehensive income (loss)	10,094					10,094
Forfeiture of restricted stock award grants	0		77		(77)
Stock-based compensation expense	471		471
Purchase of treasury stock for the purpose of tax withholding related to restricted stock award vesting							$ (1)		$ (1)
Preferred cash dividend declared	(1,076)			(1,076)
Cash dividends declared	(3,779)			(3,779)
Ending balance at Sep. 30, 2024	$ 606,363	$ 57,785	$ 219,304	$ 371,086	$ (4,516)	$ (37,296)